Raymond James & Associates’s Cempra, Inc. CEMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-12,170
Closed -$34K 3460
2016
Q4
$34K Sell
12,170
-38,850
-76% -$471K ﹤0.01% 3120
2016
Q3
$1.24M Buy
51,020
+30,500
+149% +$657K ﹤0.01% 1750
2016
Q2
$338K Sell
20,520
-2,700
-12% -$47.6K ﹤0.01% 2340
2016
Q1
$407K Buy
23,220
+11,253
+94% +$204K ﹤0.01% 2157
2015
Q4
$373K Buy
+11,967
New +$333K ﹤0.01% 2113
2015
Q3
Sell
-12,310
Closed -$423K 2437
2015
Q2
$423K Buy
12,310
+490
+4% +$17.3K ﹤0.01% 2159
2015
Q1
$406K Buy
+11,820
New +$355K ﹤0.01% 2119

Other funds holding CEMP

Raymond James & Associates's CEMP Position: Q1 2017 in Review

Raymond James & Associates sold out of Cempra, Inc. (CEMP) in Q1 2017, closing a stake of 12,170 shares — an estimated $34K sold.

Raymond James & Associates first reported a position in CEMP in Q1 2015 and held it in 7 quarters. The position peaked at $1.24M in Q3 2016. 107 funds tracked by Wall St. Rank hold CEMP as of Q1 2017.

  • Raymond James & Associates reported no remaining Cempra, Inc. position as of Q1 2017 after selling out during the quarter.
  • Raymond James & Associates sold 12,170 Cempra, Inc. shares in Q1 2017, an estimated $34K.
  • Raymond James & Associates first reported a position in Cempra, Inc. in Q1 2015 and held it in 7 quarters.
  • Raymond James & Associates's Cempra, Inc. position peaked at $1.24M in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Cempra, Inc. as of Q1 2017.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.